Phase II study of weekly albumin-bound paclitaxel combined with cisplatin in patients with advanced breast cancer

被引：0
|
作者：
Hu, X. [1 ]
Wang, B. [1 ]
机构：
[1] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
来源：
BREAST | 2011年 / 20卷
关键词：
D O I：
10.1016/S0960-9776(11)70254-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [1] A phase II study of weekly nanoparticle albumin-bound paclitaxel combined with cisplatin in patients with metastatic breast cancer
    Wang, Biyun
    Hu, Xi-Chun
    Sun, Si
    Zhang, Jian
    Tang, Lichen
    Wang, Zhong Hua
    Wang, Lei Ping
    Lv, Fangfang
    Zhang, Qunling
    Zheng, Chunlei
    Jia, Zhen
    Lu, Yunhua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes
    Blum, Joanne L.
    Savin, Michael A.
    Edelman, Gerald
    Pippen, John E.
    Robert, Nicholas J.
    Geister, Brian V.
    Kirby, Robert L.
    Clawson, Alicia
    O'Shaughnessy, Joyce A.
    CLINICAL BREAST CANCER, 2007, 7 (11) : 850 - 856
  • [3] A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer
    Mirtsching, Barry
    Cosgriff, Thomas
    Harker, Graydon
    Keaton, Mark
    Chidiac, Tarek
    Min, Myo
    CLINICAL BREAST CANCER, 2011, 11 (02) : 121 - 128
  • [4] Phase II study of neoadjuvant weekly albumin-bound paclitaxel for node-positive breast cancer
    Hattori, A.
    Hirano, A.
    Ogura, K.
    Inoue, H.
    Okubo, F.
    Miyamoto, R.
    Jibiki, N.
    Fujibayashi, M.
    Shimizu, T.
    BREAST, 2015, 24 : S92 - S92
  • [5] Phase I study of combination therapy with weekly nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with advanced or recurrent breast cancer
    Ota, D.
    Akatsuka, S.
    Nishi, T.
    Kato, T.
    Takeuchi, M.
    Munechika, T.
    Inagaki, M.
    Fukuuchi, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S283 - S283
  • [6] HIGHER RATE OF SKIN RASH IN A PHASE II TRIAL WITH WEEKLY NANOPARTICLE ALBUMIN-BOUND PACLITAXEL AND CISPLATIN COMBINATION IN CHINESE BREAST CANCER PATIENTS
    Tang, L.
    Wang, B.
    Di, G.
    Shao, Z.
    Hu, X.
    ANNALS OF ONCOLOGY, 2011, 22 : 56 - 57
  • [7] Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients
    Tang, Li Chen
    Wang, Bi Yun
    Sun, Si
    Zhang, Jian
    Jia, Zhen
    Lu, Yun Hua
    Di, Geng Hong
    Shao, Zhi Ming
    Hu, Xi Chun
    BMC CANCER, 2013, 13
  • [8] Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients
    Li Chen Tang
    Bi Yun Wang
    Si Sun
    Jian Zhang
    Zhen Jia
    Yun Hua Lu
    Geng Hong Di
    Zhi Ming Shao
    Xi Chun Hu
    BMC Cancer, 13
  • [9] SAFETY OF WEEKLY ADMINISTRATION OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL IN PATIENTS WITH BREAST CANCER
    Seki, H.
    Asanuma, F.
    Yamada, Y.
    Hirata, Y.
    Kaneda, M.
    Suzuki, K.
    Osaku, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E41 - E41
  • [10] Albumin-bound paclitaxel (Abraxane) for advanced breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1208): : 39 - 40
12345